Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001859061-23-000007
Filing Date
2023-06-02
Accepted
2023-06-02 17:00:32
Documents
1
Period of Report
2023-05-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5221
  Complete submission text file 0001859061-23-000007.txt   6766
Mailing Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063
Business Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063 (650) 980-9099
Biomea Fusion, Inc. (Issuer) CIK: 0001840439 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 59 5TH AVE NEW YORK NY 10003
Business Address 59 5TH AVE NEW YORK NY 10003 (914) 841-8818
A2A Pharmaceuticals, Inc. (Reporting) CIK: 0001859061 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40335 | Film No.: 23989913